Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences ADME and Predictive Toxicology

Thomas Joos's Biography



Thomas Joos, Deputy Managing Director, University of Tuebingen

Dr. Joos joined 1998 the NMI at the University of Tuebingen heading the department of biochemistry. Since 2013 he is the deputy managing director. His research is focused on miniaturized multiplexed immunoassays for biomarker research and diagnostic applications. Dr. Joos studied Biochemistry at the University of Tübingen. He performed his Ph.D. degree in 1985 on integrin-?5 during early embroygenesis of Xenopus laevis in the laboratory of Prof. Peter Hausen at the Max-Planck-Institute of Developmental Biology. Dr. Joos is a member of the editorial board of Drug Discovery Today, Proteomics, Molecular Biotechnology and Expert Review of Proteomics. He is a member of the scientific advisory board of the "Plasma Proteome Institute" Washington, DC, USA, of the “AlbaNova VINN Excellence Centre for Protein Technology (ProNova)” at the Royal Institute of Technology, Stockholm, Sweden, and of Myriad-RBM, Austin, TX, USA.

Thomas Joos Image

Biomarker to Analyze Drug-induced Injuries of Kidney, Liver and the Vascular System

Thursday, 11 April 2013 at 10:00

Add to Calendar ▼2013-04-11 10:00:002013-04-11 11:00:00Europe/LondonBiomarker to Analyze Drug-induced Injuries of Kidney, Liver and the Vascular SystemADME and Predictive Toxicology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

The presentation will focus on the definition of clinical qualification processes for safety biomarkers and will address our biomarker candidate selection criteria.


Add to Calendar ▼2013-04-11 00:00:002013-04-12 00:00:00Europe/LondonADME and Predictive ToxicologyADME and Predictive Toxicology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com